[HTML][HTML] Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis
CM Yamashita, L Dolgonos, RL Zemans… - The American journal of …, 2011 - Elsevier
Idiopathic pulmonary fibrosis (IPF) may be triggered by epithelial injury that results in
aberrant production of growth factors, cytokines, and proteinases, leading to proliferation of …
aberrant production of growth factors, cytokines, and proteinases, leading to proliferation of …
On, around, and through: neutrophil-endothelial interactions in innate immunity
This manuscript will review our current understanding of neutrophilic polymorphonuclear
leukocyte (neutrophil) interactions with the endothelium during immune and inflammatory …
leukocyte (neutrophil) interactions with the endothelium during immune and inflammatory …
Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS
… Drs Aschner, Zemans, and Yamashita have reported that no potential conflicts of interest
exist with any companies/organizations whose products or services may be discussed in this …
exist with any companies/organizations whose products or services may be discussed in this …
[HTML][HTML] Asthma control, airway mucus, and 129Xe MRI ventilation after a single benralizumab dose
…, CA Mackenzie, S Svenningsen, P Nair, C Yamashita… - Chest, 2022 - Elsevier
Background Patients with eosinophilic asthma often report poor symptomatic control and
quality of life. Anti-IL-5 therapy, including anti-IL-5Rα (benralizumab), rapidly depletes …
quality of life. Anti-IL-5 therapy, including anti-IL-5Rα (benralizumab), rapidly depletes …
Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia
…, HP Haagsman, YY Zuo, CM Yamashita… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Antibiotic-resistant bacterial infections represent an emerging health concern in clinical
settings, and a lack of novel developments in the pharmaceutical pipeline is creating a “perfect …
settings, and a lack of novel developments in the pharmaceutical pipeline is creating a “perfect …
Leukocyte elastase induces lung epithelial apoptosis via a Par-1–, Nf-κb–, and P53-dependent pathway
T Suzuki, C Yamashita, RL Zemans… - American journal of …, 2009 - atsjournals.org
Leukocyte elastase induces apoptosis of lung epithelial cells via alterations in mitochondrial
permeability, but the signaling pathways regulating this response remain uncertain. Here …
permeability, but the signaling pathways regulating this response remain uncertain. Here …
Lung remodeling associated with recovery from acute lung injury
SE Gill, CM Yamashita, RAW Veldhuizen - Cell and tissue research, 2017 - Springer
Acute respiratory distress syndrome (ARDS) is a disease with a variety of causes and is
defined by severe hypoxemia. Whereas ARDS carries a mortality of approximately 30 %, …
defined by severe hypoxemia. Whereas ARDS carries a mortality of approximately 30 %, …
[HTML][HTML] CT mucus score and 129Xe MRI ventilation defects after 2.5 years' anti-IL-5Rα in eosinophilic asthma
…, A Bhalla, C Licskai, CA Mackenzie, C Yamashita… - Chest, 2023 - Elsevier
Background We previously showed in patients with poorly controlled eosinophilic asthma
that a single dose of benralizumab resulted in significantly improved Asthma Control …
that a single dose of benralizumab resulted in significantly improved Asthma Control …
[HTML][HTML] 129Xe MRI ventilation defects in asthma: what is the upper limit of normal and minimal clinically important difference?
…, HK Kooner, A Bhalla, H Serajeddini, C Yamashita… - Academic …, 2023 - Elsevier
Rationale and Objectives The minimal clinically important difference (MCID) and upper limit
of normal (ULN) for MRI ventilation defect percent (VDP) were previously reported for …
of normal (ULN) for MRI ventilation defect percent (VDP) were previously reported for …
Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In Vivo
…, BJH Banaschewski, BJ Baer, C Yamashita… - Infection and …, 2017 - Am Soc Microbiol
The development of antibiotic resistance by Pseudomonas aeruginosa is a major concern
in the treatment of bacterial pneumonia. In the search for novel anti-infective therapies, the …
in the treatment of bacterial pneumonia. In the search for novel anti-infective therapies, the …